The wrist has officially been slapped.
Busted up Ultimate Fighting Championship (UFC) veteran Nate Diaz was playing doctor in the wake of his five-round war with Conor McGregor at the UFC 202 pay-per-view (PPV) event, which took place last August inside T-Mobile Arena in Las Vegas, Nevada.
Doctor’s orders? A few puffs of the vape pen during the UFC 202 post-fight press conference (watch it), which just so happened to contain cannibidiol oil, also known as CBD.
United States Anti-Doping Agency (USADA), charged with going overboard keeping the drug-testing peace in UFC immediately launched an investigation, as CBD belongs to the cannabis family, banned in-competition by World Anti-Doping Agency (WADA).
“On Thursday, the anti-doping agency stated Diaz mistakenly believed the timeframe in which Cannabinoids are banned ended immediately after the fight,” ESPN’s Brett Okamoto said. “Which is the case under the rules of the Nevada State Athletic Commission.”
It’s easy to get confused.
Diaz (19-11) has not failed a pre- or post-fight drug test during his 12-year career in mixed martial arts (MMA) and UFC 202 was no exception, which is probably why USADA felt a verbal warning was appropriate.
Move along, nothing to see here.